GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
BATF
|
ENSG00000156127.6 | basic leucine zipper ATF-like transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BATF | hg19_v2_chr14_+_75988851_75988903 | -0.23 | 6.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_223889285 | 54.48 |
ENST00000433674.2
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr6_-_31704282 | 39.29 |
ENST00000375784.3
ENST00000375779.2 |
CLIC1
|
chloride intracellular channel 1 |
chr11_-_33744487 | 38.26 |
ENST00000426650.2
|
CD59
|
CD59 molecule, complement regulatory protein |
chr5_+_159848854 | 37.54 |
ENST00000517480.1
ENST00000520452.1 ENST00000393964.1 |
PTTG1
|
pituitary tumor-transforming 1 |
chr11_-_33743952 | 36.14 |
ENST00000534312.1
|
CD59
|
CD59 molecule, complement regulatory protein |
chr6_+_63921399 | 34.58 |
ENST00000356170.3
|
FKBP1C
|
FK506 binding protein 1C |
chr16_-_69760409 | 32.59 |
ENST00000561500.1
ENST00000439109.2 ENST00000564043.1 ENST00000379046.2 ENST00000379047.3 |
NQO1
|
NAD(P)H dehydrogenase, quinone 1 |
chr2_+_10262442 | 30.14 |
ENST00000360566.2
|
RRM2
|
ribonucleotide reductase M2 |
chr1_-_151965048 | 30.05 |
ENST00000368809.1
|
S100A10
|
S100 calcium binding protein A10 |
chr17_-_79481666 | 28.22 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
chr4_-_84035905 | 27.75 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
chr3_-_149095652 | 27.61 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr3_-_81792780 | 27.41 |
ENST00000489715.1
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1 |
chr2_-_106013400 | 27.22 |
ENST00000409807.1
|
FHL2
|
four and a half LIM domains 2 |
chr5_+_135394840 | 27.16 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr4_-_174254823 | 26.84 |
ENST00000438704.2
|
HMGB2
|
high mobility group box 2 |
chr5_+_159848807 | 26.20 |
ENST00000352433.5
|
PTTG1
|
pituitary tumor-transforming 1 |
chr8_+_55047763 | 25.65 |
ENST00000260102.4
ENST00000519831.1 |
MRPL15
|
mitochondrial ribosomal protein L15 |
chr15_-_60690163 | 25.02 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
chr5_+_73980965 | 24.08 |
ENST00000261416.7
|
HEXB
|
hexosaminidase B (beta polypeptide) |
chr22_+_23241661 | 23.89 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr11_-_2950642 | 23.70 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
chr6_+_63921351 | 22.79 |
ENST00000370659.1
|
FKBP1C
|
FK506 binding protein 1C |
chr1_-_24126023 | 22.61 |
ENST00000429356.1
|
GALE
|
UDP-galactose-4-epimerase |
chr2_-_85637459 | 22.56 |
ENST00000409921.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr20_+_47835884 | 22.34 |
ENST00000371764.4
|
DDX27
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 |
chr5_+_65222384 | 22.17 |
ENST00000380943.2
ENST00000416865.2 ENST00000380939.2 ENST00000380936.1 ENST00000380935.1 |
ERBB2IP
|
erbb2 interacting protein |
chr6_+_44194762 | 22.09 |
ENST00000371708.1
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
chr9_+_75766652 | 21.40 |
ENST00000257497.6
|
ANXA1
|
annexin A1 |
chr1_-_225616515 | 21.31 |
ENST00000338179.2
ENST00000425080.1 |
LBR
|
lamin B receptor |
chr6_-_138428613 | 20.67 |
ENST00000421351.3
|
PERP
|
PERP, TP53 apoptosis effector |
chr11_-_64013288 | 20.54 |
ENST00000542235.1
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr7_-_87856303 | 20.50 |
ENST00000394641.3
|
SRI
|
sorcin |
chr14_+_35747825 | 20.48 |
ENST00000540871.1
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6 |
chr1_+_26605618 | 20.26 |
ENST00000270792.5
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr12_+_96252706 | 20.23 |
ENST00000266735.5
ENST00000553192.1 ENST00000552085.1 |
SNRPF
|
small nuclear ribonucleoprotein polypeptide F |
chr1_-_113247543 | 19.80 |
ENST00000414971.1
ENST00000534717.1 |
RHOC
|
ras homolog family member C |
chr1_+_158979686 | 19.55 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_-_225615599 | 19.27 |
ENST00000421383.1
ENST00000272163.4 |
LBR
|
lamin B receptor |
chr9_+_42704004 | 19.22 |
ENST00000457288.1
|
CBWD7
|
COBW domain containing 7 |
chr2_+_90060377 | 19.16 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr1_-_209824643 | 19.07 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr1_+_26606608 | 18.94 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr10_+_17270214 | 18.75 |
ENST00000544301.1
|
VIM
|
vimentin |
chr12_+_69979113 | 18.61 |
ENST00000299300.6
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr7_-_7680601 | 18.54 |
ENST00000396682.2
|
RPA3
|
replication protein A3, 14kDa |
chr1_+_158979792 | 18.47 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr15_+_80364901 | 18.19 |
ENST00000560228.1
ENST00000559835.1 ENST00000559775.1 ENST00000558688.1 ENST00000560392.1 ENST00000560976.1 ENST00000558272.1 ENST00000558390.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
chr2_-_152146385 | 18.14 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr1_+_158900568 | 18.00 |
ENST00000458222.1
|
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr6_-_24667180 | 17.86 |
ENST00000545995.1
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2 |
chr3_+_33155525 | 17.83 |
ENST00000449224.1
|
CRTAP
|
cartilage associated protein |
chr1_-_152009460 | 17.75 |
ENST00000271638.2
|
S100A11
|
S100 calcium binding protein A11 |
chr6_-_24666819 | 17.66 |
ENST00000341060.3
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2 |
chr14_+_55590646 | 17.54 |
ENST00000553493.1
|
LGALS3
|
lectin, galactoside-binding, soluble, 3 |
chr17_+_18625336 | 17.53 |
ENST00000395671.4
ENST00000571542.1 ENST00000395672.2 ENST00000414850.2 ENST00000424146.2 |
TRIM16L
|
tripartite motif containing 16-like |
chr5_+_65222299 | 17.45 |
ENST00000284037.5
|
ERBB2IP
|
erbb2 interacting protein |
chr10_+_106014468 | 17.32 |
ENST00000369710.4
ENST00000369713.5 ENST00000445155.1 |
GSTO1
|
glutathione S-transferase omega 1 |
chr7_+_73106926 | 17.26 |
ENST00000453316.1
|
WBSCR22
|
Williams Beuren syndrome chromosome region 22 |
chr2_-_85641162 | 17.25 |
ENST00000447219.2
ENST00000409670.1 ENST00000409724.1 |
CAPG
|
capping protein (actin filament), gelsolin-like |
chr22_+_23046750 | 17.17 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
chr3_+_30647994 | 16.95 |
ENST00000295754.5
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr3_+_30648066 | 16.93 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr11_+_101983176 | 16.63 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr2_-_89417335 | 16.61 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr2_+_201981527 | 16.59 |
ENST00000441224.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_+_156084461 | 16.50 |
ENST00000347559.2
ENST00000361308.4 ENST00000368300.4 ENST00000368299.3 |
LMNA
|
lamin A/C |
chr1_+_158979680 | 16.46 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr12_-_53343602 | 16.43 |
ENST00000546897.1
ENST00000552551.1 |
KRT8
|
keratin 8 |
chr11_-_64013663 | 16.38 |
ENST00000392210.2
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr17_-_73150629 | 16.27 |
ENST00000356033.4
ENST00000405458.3 ENST00000409753.3 |
HN1
|
hematological and neurological expressed 1 |
chr8_-_124037890 | 16.27 |
ENST00000519018.1
ENST00000523036.1 |
DERL1
|
derlin 1 |
chr5_+_138089100 | 16.18 |
ENST00000520339.1
ENST00000355078.5 ENST00000302763.7 ENST00000518910.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr12_+_123237321 | 16.17 |
ENST00000280557.6
ENST00000455982.2 |
DENR
|
density-regulated protein |
chr13_+_28195988 | 16.12 |
ENST00000399697.3
ENST00000399696.1 |
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
chr4_-_84035868 | 15.94 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
chr19_+_14672755 | 15.90 |
ENST00000594545.1
|
TECR
|
trans-2,3-enoyl-CoA reductase |
chr2_+_90198535 | 15.80 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr12_+_75874460 | 15.80 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr11_-_33744256 | 15.64 |
ENST00000415002.2
ENST00000437761.2 ENST00000445143.2 |
CD59
|
CD59 molecule, complement regulatory protein |
chr12_-_15104040 | 15.59 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr14_+_20937538 | 15.54 |
ENST00000361505.5
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
chr1_+_148560843 | 15.37 |
ENST00000442702.2
ENST00000369187.3 |
NBPF15
|
neuroblastoma breakpoint family, member 15 |
chr15_-_85259294 | 15.36 |
ENST00000558217.1
ENST00000558196.1 ENST00000558134.1 |
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr2_+_192141611 | 15.35 |
ENST00000392316.1
|
MYO1B
|
myosin IB |
chr1_+_156095951 | 15.34 |
ENST00000448611.2
ENST00000368297.1 |
LMNA
|
lamin A/C |
chrX_+_64887512 | 15.32 |
ENST00000360270.5
|
MSN
|
moesin |
chr3_+_150321068 | 15.04 |
ENST00000471696.1
ENST00000477889.1 ENST00000485923.1 |
SELT
|
Selenoprotein T |
chr6_-_24667232 | 14.98 |
ENST00000378198.4
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2 |
chr2_+_201997492 | 14.93 |
ENST00000494258.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_-_89458636 | 14.83 |
ENST00000370486.1
ENST00000399794.2 |
CCBL2
RBMXL1
|
cysteine conjugate-beta lyase 2 RNA binding motif protein, X-linked-like 1 |
chr12_+_13349650 | 14.78 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
chr3_+_127771212 | 14.75 |
ENST00000243253.3
ENST00000481210.1 |
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae) |
chr2_+_109204909 | 14.53 |
ENST00000393310.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr15_-_85259330 | 14.47 |
ENST00000560266.1
|
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr5_+_172386419 | 14.45 |
ENST00000265100.2
ENST00000519239.1 |
RPL26L1
|
ribosomal protein L26-like 1 |
chr2_-_170681324 | 14.29 |
ENST00000409340.1
|
METTL5
|
methyltransferase like 5 |
chr10_+_88854926 | 14.27 |
ENST00000298784.1
ENST00000298786.4 |
FAM35A
|
family with sequence similarity 35, member A |
chr15_-_55563072 | 14.05 |
ENST00000567380.1
ENST00000565972.1 ENST00000569493.1 |
RAB27A
|
RAB27A, member RAS oncogene family |
chr5_+_72143988 | 13.91 |
ENST00000506351.2
|
TNPO1
|
transportin 1 |
chr2_+_201936707 | 13.87 |
ENST00000433898.1
ENST00000454214.1 |
NDUFB3
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa |
chr2_-_89513402 | 13.87 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr7_+_48128194 | 13.84 |
ENST00000416681.1
ENST00000331803.4 ENST00000432131.1 |
UPP1
|
uridine phosphorylase 1 |
chr3_-_150320937 | 13.79 |
ENST00000479209.1
|
SERP1
|
stress-associated endoplasmic reticulum protein 1 |
chr17_-_8113542 | 13.78 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr13_-_41593425 | 13.76 |
ENST00000239882.3
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
chr14_-_94854926 | 13.67 |
ENST00000402629.1
ENST00000556091.1 ENST00000554720.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr9_-_127177703 | 13.54 |
ENST00000259457.3
ENST00000536392.1 ENST00000441097.1 |
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7 |
chr7_+_55177416 | 13.53 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr3_-_49066811 | 13.49 |
ENST00000442157.1
ENST00000326739.4 |
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
chr18_-_33702078 | 13.48 |
ENST00000586829.1
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6 |
chr15_+_22892663 | 13.39 |
ENST00000313077.7
ENST00000561274.1 ENST00000560848.1 |
CYFIP1
|
cytoplasmic FMR1 interacting protein 1 |
chr7_+_48128316 | 13.33 |
ENST00000341253.4
|
UPP1
|
uridine phosphorylase 1 |
chr12_-_56120865 | 13.31 |
ENST00000548898.1
ENST00000552067.1 |
CD63
|
CD63 molecule |
chr6_-_41909561 | 13.12 |
ENST00000372991.4
|
CCND3
|
cyclin D3 |
chr13_+_53216565 | 12.78 |
ENST00000357495.2
|
HNRNPA1L2
|
heterogeneous nuclear ribonucleoprotein A1-like 2 |
chr7_+_30634297 | 12.77 |
ENST00000389266.3
|
GARS
|
glycyl-tRNA synthetase |
chr2_+_90139056 | 12.77 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr7_-_87856280 | 12.75 |
ENST00000490437.1
ENST00000431660.1 |
SRI
|
sorcin |
chr11_+_35198118 | 12.72 |
ENST00000525211.1
ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44
|
CD44 molecule (Indian blood group) |
chr6_-_2842087 | 12.72 |
ENST00000537185.1
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
chr3_-_185641681 | 12.71 |
ENST00000259043.7
|
TRA2B
|
transformer 2 beta homolog (Drosophila) |
chr6_-_159239257 | 12.66 |
ENST00000337147.7
ENST00000392177.4 |
EZR
|
ezrin |
chrX_+_23682379 | 12.62 |
ENST00000379349.1
|
PRDX4
|
peroxiredoxin 4 |
chr11_-_65667997 | 12.54 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr2_-_3595547 | 12.52 |
ENST00000438485.1
|
RP13-512J5.1
|
Uncharacterized protein |
chr17_-_7590745 | 12.48 |
ENST00000514944.1
ENST00000503591.1 ENST00000455263.2 ENST00000420246.2 ENST00000445888.2 ENST00000509690.1 ENST00000604348.1 ENST00000269305.4 |
TP53
|
tumor protein p53 |
chr18_+_3247779 | 12.42 |
ENST00000578611.1
ENST00000583449.1 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
chr11_-_65667884 | 12.29 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr19_+_49377575 | 12.19 |
ENST00000600406.1
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A |
chr17_+_49230897 | 12.15 |
ENST00000393196.3
ENST00000336097.3 ENST00000480143.1 ENST00000511355.1 ENST00000013034.3 ENST00000393198.3 ENST00000608447.1 ENST00000393193.2 ENST00000376392.6 ENST00000555572.1 |
NME1
NME1-NME2
NME2
|
NME/NM23 nucleoside diphosphate kinase 1 NME1-NME2 readthrough NME/NM23 nucleoside diphosphate kinase 2 |
chr4_-_143227088 | 12.11 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr15_-_85259384 | 12.08 |
ENST00000455959.3
|
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr3_-_47823298 | 12.07 |
ENST00000254480.5
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
chr4_+_17616253 | 12.07 |
ENST00000237380.7
|
MED28
|
mediator complex subunit 28 |
chr8_-_102217796 | 12.06 |
ENST00000519744.1
ENST00000311212.4 ENST00000521272.1 ENST00000519882.1 |
ZNF706
|
zinc finger protein 706 |
chr2_+_27435734 | 12.05 |
ENST00000419744.1
|
ATRAID
|
all-trans retinoic acid-induced differentiation factor |
chr19_+_52932435 | 12.01 |
ENST00000301085.4
|
ZNF534
|
zinc finger protein 534 |
chr1_+_174844645 | 11.99 |
ENST00000486220.1
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr11_+_18417813 | 11.96 |
ENST00000540430.1
ENST00000379412.5 |
LDHA
|
lactate dehydrogenase A |
chr12_-_76478686 | 11.96 |
ENST00000261182.8
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr11_+_20385327 | 11.95 |
ENST00000451739.2
ENST00000532505.1 |
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa |
chr9_+_71819927 | 11.95 |
ENST00000535702.1
|
TJP2
|
tight junction protein 2 |
chr20_-_1373682 | 11.94 |
ENST00000381724.3
|
FKBP1A
|
FK506 binding protein 1A, 12kDa |
chr2_-_89266286 | 11.82 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr12_+_75874580 | 11.80 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr17_+_1936687 | 11.75 |
ENST00000570477.1
|
DPH1
|
diphthamide biosynthesis 1 |
chr17_+_21191341 | 11.63 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr8_-_67977178 | 11.63 |
ENST00000517736.1
|
COPS5
|
COP9 signalosome subunit 5 |
chr7_+_128399002 | 11.52 |
ENST00000493278.1
|
CALU
|
calumenin |
chr5_-_179051579 | 11.51 |
ENST00000505811.1
ENST00000515714.1 ENST00000513225.1 ENST00000503664.1 ENST00000356731.5 ENST00000523137.1 |
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H) |
chr2_+_161993412 | 11.45 |
ENST00000259075.2
ENST00000432002.1 |
TANK
|
TRAF family member-associated NFKB activator |
chr12_-_2986107 | 11.43 |
ENST00000359843.3
ENST00000342628.2 ENST00000361953.3 |
FOXM1
|
forkhead box M1 |
chr3_+_160117087 | 11.43 |
ENST00000357388.3
|
SMC4
|
structural maintenance of chromosomes 4 |
chr19_+_13051206 | 11.41 |
ENST00000586760.1
|
CALR
|
calreticulin |
chr1_-_193074504 | 11.40 |
ENST00000367439.3
|
GLRX2
|
glutaredoxin 2 |
chr5_+_32585605 | 11.40 |
ENST00000265073.4
ENST00000515355.1 ENST00000502897.1 ENST00000510442.1 |
SUB1
|
SUB1 homolog (S. cerevisiae) |
chr3_-_149093499 | 11.40 |
ENST00000472441.1
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr18_-_51751132 | 11.36 |
ENST00000256429.3
|
MBD2
|
methyl-CpG binding domain protein 2 |
chr12_-_56122426 | 11.32 |
ENST00000551173.1
|
CD63
|
CD63 molecule |
chrX_+_118602363 | 11.32 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr2_+_201997595 | 11.26 |
ENST00000470178.2
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_-_19746236 | 11.23 |
ENST00000375144.1
|
CAPZB
|
capping protein (actin filament) muscle Z-line, beta |
chr6_+_24667257 | 11.22 |
ENST00000537591.1
ENST00000230048.4 |
ACOT13
|
acyl-CoA thioesterase 13 |
chr21_-_46237883 | 11.13 |
ENST00000397893.3
|
SUMO3
|
small ubiquitin-like modifier 3 |
chr12_-_76462713 | 11.05 |
ENST00000552056.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr2_-_151344172 | 11.03 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr16_-_75681522 | 11.02 |
ENST00000568378.1
ENST00000568682.1 ENST00000570215.1 ENST00000319410.5 ENST00000302445.3 |
KARS
|
lysyl-tRNA synthetase |
chr6_-_137539651 | 10.95 |
ENST00000543628.1
|
IFNGR1
|
interferon gamma receptor 1 |
chr2_+_89923550 | 10.93 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr10_+_17686124 | 10.91 |
ENST00000377524.3
|
STAM
|
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
chr12_+_27863706 | 10.84 |
ENST00000081029.3
ENST00000538315.1 ENST00000542791.1 |
MRPS35
|
mitochondrial ribosomal protein S35 |
chr15_-_77376269 | 10.79 |
ENST00000558745.1
|
TSPAN3
|
tetraspanin 3 |
chr15_+_89181974 | 10.78 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr5_-_96518907 | 10.78 |
ENST00000508447.1
ENST00000283109.3 |
RIOK2
|
RIO kinase 2 |
chr20_-_1373726 | 10.76 |
ENST00000400137.4
|
FKBP1A
|
FK506 binding protein 1A, 12kDa |
chr17_-_65362678 | 10.75 |
ENST00000357146.4
ENST00000356126.3 |
PSMD12
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
chr17_-_39681578 | 10.74 |
ENST00000593096.1
|
KRT19
|
keratin 19 |
chr12_-_50419177 | 10.73 |
ENST00000454520.2
ENST00000546595.1 ENST00000548824.1 ENST00000549777.1 ENST00000546723.1 ENST00000427314.2 ENST00000552157.1 ENST00000552310.1 ENST00000548644.1 ENST00000312377.5 ENST00000546786.1 ENST00000550149.1 ENST00000546764.1 ENST00000552004.1 ENST00000548320.1 ENST00000547905.1 ENST00000550651.1 ENST00000551145.1 ENST00000434422.1 ENST00000552921.1 |
RACGAP1
|
Rac GTPase activating protein 1 |
chr1_+_45477819 | 10.71 |
ENST00000246337.4
|
UROD
|
uroporphyrinogen decarboxylase |
chr2_+_216974020 | 10.64 |
ENST00000392132.2
ENST00000417391.1 |
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) |
chr1_-_246580705 | 10.64 |
ENST00000541742.1
|
SMYD3
|
SET and MYND domain containing 3 |
chr1_+_53392901 | 10.62 |
ENST00000371514.3
ENST00000528311.1 ENST00000371509.4 ENST00000407246.2 ENST00000371513.5 |
SCP2
|
sterol carrier protein 2 |
chr2_-_113594279 | 10.62 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr12_-_56122761 | 10.59 |
ENST00000552164.1
ENST00000420846.3 ENST00000257857.4 |
CD63
|
CD63 molecule |
chr1_-_109968973 | 10.53 |
ENST00000271308.4
ENST00000538610.1 |
PSMA5
|
proteasome (prosome, macropain) subunit, alpha type, 5 |
chrX_-_109561294 | 10.51 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr12_-_48099754 | 10.51 |
ENST00000380650.4
|
RPAP3
|
RNA polymerase II associated protein 3 |
chr12_+_16109519 | 10.44 |
ENST00000526530.1
|
DERA
|
deoxyribose-phosphate aldolase (putative) |
chr3_+_133293278 | 10.44 |
ENST00000508481.1
ENST00000420115.2 ENST00000504867.1 ENST00000507408.1 ENST00000511392.1 ENST00000515421.1 |
CDV3
|
CDV3 homolog (mouse) |
chr12_-_48099773 | 10.36 |
ENST00000432584.3
ENST00000005386.3 |
RPAP3
|
RNA polymerase II associated protein 3 |
chr11_-_104817919 | 10.35 |
ENST00000533252.1
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
chr5_-_10761206 | 10.32 |
ENST00000432074.2
ENST00000230895.6 |
DAP
|
death-associated protein |
chr3_+_183894566 | 10.23 |
ENST00000439647.1
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit |
chr2_-_89459813 | 10.23 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr9_+_71820057 | 10.23 |
ENST00000539225.1
|
TJP2
|
tight junction protein 2 |
chr2_+_89998789 | 10.20 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chrX_-_77225135 | 10.18 |
ENST00000458128.1
|
PGAM4
|
phosphoglycerate mutase family member 4 |
chr7_+_128379346 | 10.13 |
ENST00000535011.2
ENST00000542996.2 ENST00000535623.1 ENST00000538546.1 ENST00000249364.4 ENST00000449187.2 |
CALU
|
calumenin |
chr15_-_59225758 | 10.11 |
ENST00000558486.1
ENST00000560682.1 ENST00000249736.7 ENST00000559880.1 ENST00000536328.1 |
SLTM
|
SAFB-like, transcription modulator |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.5 | 90.0 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
11.3 | 33.9 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
8.4 | 25.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
8.3 | 25.0 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
7.7 | 38.6 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
7.4 | 29.6 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
7.1 | 21.4 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
6.8 | 27.2 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
6.2 | 18.6 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
6.0 | 18.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
6.0 | 17.9 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
5.9 | 23.8 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
5.9 | 17.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
5.9 | 23.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
5.7 | 28.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
5.5 | 32.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
5.4 | 27.2 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
5.4 | 16.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
5.4 | 16.2 | GO:0002188 | translation reinitiation(GO:0002188) |
5.3 | 74.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
5.2 | 15.5 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) inosine metabolic process(GO:0046102) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
5.0 | 49.5 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
4.8 | 24.1 | GO:0007619 | courtship behavior(GO:0007619) |
4.8 | 14.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
4.6 | 13.8 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
4.5 | 13.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
4.4 | 22.1 | GO:0015862 | uridine transport(GO:0015862) |
4.4 | 13.1 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
4.2 | 12.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oxidative stress-induced premature senescence(GO:0090403) oligodendrocyte apoptotic process(GO:0097252) |
4.1 | 24.8 | GO:0007296 | vitellogenesis(GO:0007296) |
4.1 | 12.2 | GO:1902310 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
4.0 | 4.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
3.9 | 15.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
3.7 | 18.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
3.7 | 48.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
3.6 | 25.3 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
3.6 | 18.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
3.5 | 10.6 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
3.5 | 10.6 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
3.4 | 10.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
3.4 | 13.7 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
3.3 | 13.4 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
3.3 | 10.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
3.3 | 13.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
3.3 | 19.8 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
3.3 | 16.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
3.2 | 12.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.0 | 15.1 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
3.0 | 21.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.9 | 8.8 | GO:1904933 | cardiac right atrium morphogenesis(GO:0003213) negative regulation of melanin biosynthetic process(GO:0048022) positive regulation of anagen(GO:0051885) mediolateral intercalation(GO:0060031) cervix development(GO:0060067) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) negative regulation of secondary metabolite biosynthetic process(GO:1900377) regulation of cell proliferation in midbrain(GO:1904933) |
2.9 | 8.7 | GO:0033341 | regulation of collagen binding(GO:0033341) |
2.8 | 8.5 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
2.8 | 2.8 | GO:0043335 | protein unfolding(GO:0043335) |
2.7 | 35.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
2.6 | 15.9 | GO:2000334 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
2.6 | 7.9 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
2.6 | 47.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
2.6 | 10.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.6 | 7.8 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
2.6 | 51.7 | GO:0006465 | signal peptide processing(GO:0006465) |
2.6 | 7.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
2.5 | 10.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
2.4 | 24.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
2.4 | 36.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
2.4 | 31.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.4 | 7.3 | GO:0070541 | response to platinum ion(GO:0070541) |
2.4 | 41.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.3 | 42.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.3 | 14.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
2.3 | 9.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.3 | 23.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
2.3 | 6.9 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.3 | 9.1 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
2.2 | 11.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
2.2 | 22.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
2.2 | 11.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
2.2 | 8.8 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
2.2 | 8.8 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
2.2 | 41.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
2.2 | 8.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
2.1 | 6.4 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
2.1 | 6.3 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
2.1 | 10.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
2.1 | 8.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
2.1 | 18.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
2.0 | 4.0 | GO:1990523 | bone regeneration(GO:1990523) |
2.0 | 15.9 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
2.0 | 11.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.0 | 7.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
1.9 | 17.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.9 | 3.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.9 | 5.7 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
1.9 | 7.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.9 | 11.3 | GO:1901029 | adenine transport(GO:0015853) negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.9 | 18.9 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.9 | 5.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.9 | 27.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
1.8 | 10.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.8 | 7.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.8 | 5.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.7 | 19.1 | GO:0002934 | desmosome organization(GO:0002934) |
1.7 | 18.9 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
1.7 | 33.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.7 | 20.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
1.7 | 5.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
1.7 | 11.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.7 | 19.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.7 | 9.9 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
1.6 | 8.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
1.6 | 8.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.6 | 4.9 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
1.6 | 17.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.6 | 6.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.6 | 12.8 | GO:0006983 | ER overload response(GO:0006983) |
1.6 | 12.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.6 | 9.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.6 | 7.9 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
1.6 | 3.2 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
1.6 | 4.7 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.6 | 4.7 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
1.6 | 18.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.6 | 6.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.6 | 4.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 4.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.5 | 9.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.5 | 68.8 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
1.5 | 1.5 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.5 | 9.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
1.5 | 132.4 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
1.5 | 7.5 | GO:0018158 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) protein oxidation(GO:0018158) |
1.5 | 5.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.5 | 23.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.5 | 4.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.5 | 11.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.4 | 11.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.4 | 5.7 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
1.4 | 15.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.4 | 2.8 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
1.4 | 12.6 | GO:0030091 | protein repair(GO:0030091) |
1.4 | 8.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.4 | 58.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.4 | 16.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.4 | 5.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.4 | 9.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.4 | 4.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.3 | 13.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.3 | 16.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.3 | 4.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
1.3 | 7.9 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.3 | 7.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.3 | 30.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.3 | 9.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.3 | 20.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
1.3 | 10.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.3 | 3.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.3 | 54.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.3 | 11.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
1.3 | 205.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.3 | 6.3 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.3 | 6.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
1.3 | 7.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.2 | 5.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.2 | 5.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.2 | 9.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.2 | 16.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.2 | 4.9 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.2 | 13.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
1.2 | 4.8 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
1.2 | 7.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
1.2 | 7.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.2 | 5.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.2 | 3.5 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
1.2 | 3.5 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
1.1 | 5.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.1 | 4.6 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
1.1 | 11.4 | GO:0042262 | DNA protection(GO:0042262) |
1.1 | 6.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.1 | 11.3 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
1.1 | 32.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 12.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.1 | 5.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
1.1 | 6.4 | GO:0090191 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
1.1 | 3.2 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
1.1 | 6.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.0 | 4.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.0 | 4.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 7.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.0 | 4.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.0 | 11.0 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
1.0 | 20.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 1.0 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.0 | 7.6 | GO:0042407 | cristae formation(GO:0042407) |
1.0 | 6.7 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.9 | 1.9 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.9 | 3.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.9 | 4.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.9 | 68.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.9 | 2.7 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.9 | 12.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.9 | 4.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.9 | 3.6 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.9 | 11.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.9 | 8.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.9 | 8.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.9 | 3.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.9 | 4.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.9 | 4.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.9 | 7.7 | GO:2000507 | cap-dependent translational initiation(GO:0002191) positive regulation of energy homeostasis(GO:2000507) |
0.9 | 19.6 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.8 | 5.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.8 | 10.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.8 | 50.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.8 | 131.0 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.8 | 19.2 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.8 | 24.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.8 | 2.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.8 | 3.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.8 | 8.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.7 | 5.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.7 | 6.7 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.7 | 2.2 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.7 | 2.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.7 | 0.7 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.7 | 2.1 | GO:1990169 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) stress response to copper ion(GO:1990169) |
0.7 | 6.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 14.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.7 | 2.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.7 | 3.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 10.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.7 | 3.4 | GO:0015840 | urea transport(GO:0015840) |
0.7 | 2.0 | GO:0042351 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.7 | 3.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 5.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.6 | 4.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.6 | 3.2 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.6 | 2.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 3.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.6 | 6.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 16.8 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.6 | 4.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.6 | 11.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.6 | 41.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 17.0 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.6 | 2.9 | GO:0051693 | actin filament capping(GO:0051693) |
0.6 | 2.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.6 | 5.7 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.6 | 11.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.6 | 5.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.6 | 4.6 | GO:0050747 | sphingomyelin biosynthetic process(GO:0006686) positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 1.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.6 | 5.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 13.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.6 | 7.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 15.4 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.5 | 2.7 | GO:0060356 | leucine import(GO:0060356) |
0.5 | 40.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.5 | 2.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 10.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.5 | 7.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.5 | 6.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.5 | 9.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.5 | 5.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 13.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.5 | 13.1 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.5 | 6.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 4.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.5 | 12.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.5 | 1.5 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.5 | 1.5 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 2.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.5 | 1.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 1.0 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.5 | 4.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.5 | 10.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 5.2 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.5 | 1.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 8.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 26.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 1.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.4 | 41.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 34.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 3.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 15.0 | GO:0006363 | transcription elongation from RNA polymerase I promoter(GO:0006362) termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 12.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.4 | 8.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 1.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.4 | 7.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 14.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 22.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 2.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 17.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.4 | 5.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 25.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 1.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 0.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.4 | 13.8 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.4 | 2.8 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.4 | 1.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.4 | 2.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 2.4 | GO:0030421 | defecation(GO:0030421) |
0.4 | 15.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 1.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.4 | 2.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.4 | 9.0 | GO:0000732 | strand displacement(GO:0000732) |
0.4 | 0.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 17.8 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.4 | 1.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.4 | 1.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.4 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 1.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.4 | 16.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 1.1 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.4 | 16.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 6.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 1.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 0.7 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 10.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 1.4 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.3 | 1.7 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 5.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 35.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 5.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.3 | 8.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.3 | 3.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 9.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 5.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.3 | 15.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.3 | 5.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 7.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 1.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 3.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 |